Last updated on August 2020

A Multicenter Randomized Double-Blind Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Ulcerative Colitis Who Have Failed Prior Biologic Therapy


Find a site near you

Start Over

Ucsd /Id# 160452

La Jolla, CA United States
  Connect »

Advanced Research Institute /ID# 161938

New Port Richey, FL United States
  Connect »

Indiana University /ID# 167252

Indianapolis, IN United States
  Connect »

Delricht Research /ID# 206815

New Orleans, LA United States
  Connect »

Gastro One /ID# 160418

Germantown, TN United States
  Connect »

Sagact Pllc /Id# 168776

San Antonio, TX United States
  Connect »

Cemic /Id# 167782

Buenos Aires, Argentina
  Connect »

Sanatorio 9 de Julio S.A. /ID# 167780

San Miguel de Tucuman, Argentina
  Connect »

UZ Brussels /ID# 164176

Jette, Brussels, Belgium
  Connect »

PMI Euromedservice /ID# 204892

Pushkin, Russian Federation
  Connect »

City Clinical Hospital #40 /ID# 203370

St. Petersburg, Russian Federation
  Connect »

Dr JP Wright /ID# 171138

Cape Town, South Africa
  Connect »

Cemic /Id# 167782

Buenos Aires, Argentina
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.